Physician
Khare, Rahul
Khare, Rahul was paid $411K by Medicaid between Aug 2020 and Jan 2023, across 16 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 26% of everything it billed.
33Billing provider infoKHARE, RAHUL
CHICAGO, IL 60657
CHICAGO, IL 60657
33aNPI1043248743assigned 06/29/2006
33bProvider typeEmergency Medicine Physician
28Total paid$411K
24GClaims9,678
24DCodes billed16
24AFirst – last monthAug 2020 – Jan 2023
Compared with peers
Next to other Emergency Medicine Physician providers in Illinois
Rank by total paid#239 of 1,980
Median peer was paid$150K
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 906 | $41K | |
| 2021 | 5,925 | $261K | |
| 2022 | 2,827 | $109K | |
| 2023 | 20 | $683.67 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 26% | 3,119 | 2,489 | $107K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 22% | 2,230 | 1,920 | $89K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 2,031 | 1,350 | $85K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 8.8% | 91 | 46 | $36K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.8% | 835 | 441 | $20K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.7% | 253 | 148 | $19K |
| 0011A | 3.0% | 540 | 457 | $12K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 2.5% | 32 | 21 | $10K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 2.4% | 26 | 14 | $10K |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 2.3% | 29 | 28 | $10K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.4% | 209 | 203 | $6K |
| 0012A | 1.3% | 178 | 162 | $5K |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.